$OKLO

DeWitte Jacob sold $1.7M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 40,000 shares of Oklo Inc. (OKLO) at $41.68 ($1.67M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Aug 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale amount and execution price may influence short-term sentiment, but the stated 10b5-1 pre-arranged plan generally lowers the signal strength for fundamentals.

02

Market read

Traders may monitor insider selling activity, but this specific disclosure is unlikely to drive a major repricing absent additional corroborating news.

03

What to watch

The article provides only one sale event; without a pattern of prior filings, it is hard to infer whether this is routine liquidity versus a change in insider behavior.

Relevance 5/10Novelty 3/10Timing: Form 4 filed Aug 5, covering an Aug 3 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Oklo Inc., reported by its co-founder and CEO.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder and CEO DeWitte Jacob sold 40,000 shares on Aug 3 at $41.68 via a 10b5-1 plan, per Form 4 filed Aug 5.

Expected impact

Limited near-term impact expected; any effect is likely short-lived unless follow-on filings show unusual selling beyond planned activity.

Evidence & confidence

The filing discloses sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or large insider sales can still be interpreted by some traders as confidence erosion, especially in early-stage growth names.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • DeWitte Jacob

    Co-Founder, CEO, and reporting insider who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SMRLowAI 8/10

NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5%

NuScale Power (SMR) fell 7% to $6.04, Energy Fuels (UUUU) dropped 9% to $8.43, and Oklo (OKLO) slid 5% to $30.11 as 10-year Treasury yields rose to 5.26%. The Global X Uranium ETF (URA) declined 4%, outpacing the broader market's 0.8% drop. Rising yields impact long-duration assets like nuclear developers, affecting both valuation and project financing costs.

$OKLOHigh

Oklo Launched Another $1 Billion Stock Sale. Here's How Much Dilution Shareholders Have Absorbed Since It Went Public.

Oklo (NYSE: OKLO), a nuclear energy company, launched a $1 billion stock sale on Sept. 11, adding to prior sales since its May 2024 SPAC merger. Outstanding shares increased 58% to 192.3 million, diluting early shareholders by 37%. Despite a 311% share price increase, Oklo's stock hit a 52-week low on Oct. 8, requiring more shares to raise the same capital.

$GOOGHighAI 8/10

Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Read-Through Investors Are Missing.

Alphabet (GOOG, GOOGL) agreed to a 15-year and 20-year deal with Constellation Energy (CEG) for nuclear power, investing $4.3B in new capacity. Oklo (OKLO) and NuScale (SMR) shares also rose, despite no direct involvement. The companies develop small modular reactors (SMRs) for specific facilities, differing from Constellation's large-scale plants. Investors see broader nuclear energy growth, with SMRs expected to play a significant role by 2050, according to industry estimates.

$OKLOMed

Oklo (OKLO) Dropped, So What Is Driving Attention Now?

Oklo, a modular nuclear reactor company, focuses on selling long-term electricity contracts. It secured NRC approval for its Aurora design, has $1.6B cash, and partnerships with NVDA, META, and Switch. However, it reports $33M net loss, no revenue, and no operating plants. Market cap is $11B. Regulatory hurdles remain.

$OKLOMed

Oklo selected for DOE isotope production initiative

Oklo Inc. (NYSE:OKLO) was chosen by the U.S. Department of Energy to advance its Groves 2 Forge facility, focusing on producing lutetium-177 for cancer treatments. The project is part of the DOE’s initiative to boost domestic nuclear reactor development and isotope production. Oklo aims to transition from pilot to commercial-scale operations with regulatory approvals.